CME Group (CME) Challenges Prediction Markets, Is The Stock Above Fair Value?

CME Group (CME) is in the spotlight after its Chairman and CEO publicly challenged the Commodity Futures Trading Commission over prediction markets, just as the company expands into new derivatives tied to sports, compute and precious metals. See our latest analysis for CME Group. For investors watching the regulatory debate play out, CME Group’s recent news comes alongside a mixed price pattern, with a 10.33% 1 month share price return but a 5.58% decline over three months, while the 5 year...